Latest News
-
HBS Reporting
Explainer: What is the impact of Philips’ recall of sleep apnea devices?
Aug 22, 2022CHICAGO, Aug 21 (Reuters) – A massive recall of Philips (PHG.AS) breathing devices in 2021 due...
-
HBS Reporting
Bluebird falls on worries over $2.8 mln gene therapy’s commercial success
Aug 22, 2022Aug 18 (Reuters) – Bluebird bio (BLUE.O) slumped nearly 15% on Thursday as investors fretted over...
-
HBS Reporting
WHO recommends use of two antibody drugs against Ebola
Aug 22, 2022GENEVA, Aug 19 (Reuters) – The World Health Organization (WHO) on Friday recommended two monoclonal antibody...
-
HBS Reporting
CVS, Walmart and Walgreens ordered to pay $650.6 million to Ohio counties in opioid case
Aug 18, 2022Aug 17 (Reuters) – Pharmacy operators CVS (CVS.N), Walmart (WMT.N) and Walgreens (WBA.O) must pay a...
-
HBS Reporting
FDA says faulty Philips device reports accelerating as CEO departs
Aug 18, 2022AMSTERDAM, Aug 17 (Reuters) – The U.S. Food and Drug Administration (FDA) said reports of faulty...
-
HBS Reporting
Bill Gates, South Korea expand global health partnership
Aug 18, 2022SEOUL, Aug 16 (Reuters) – South Korea agreed on Tuesday to expand its global health partnership...
-
HBS Reporting
Factbox: Top-selling flavored disposable e-cigarettes
Aug 18, 2022Aug 16 (Reuters) – The newest generation of e-cigarettes – disposable devices, often in sweet flavors...
-
HBS Reporting
WHO vows nothing ‘ridiculous’ as public submits ideas to rename monkeypox
Aug 18, 2022GENEVA/LONDON, Aug 16 (Reuters) – Poxy McPoxface, TRUMP-22 or Mpox: these some of the ideas sent...
-
HBS Reporting
UK first to approve Omicron COVID shot with Moderna nod
Aug 18, 2022LONDON, Aug 15 (Reuters) – Britain, the first country to approve a coronavirus vaccine in late...
-
HBS Reporting
Abortion bans limit training options for some future U.S. physicians
Aug 18, 2022Aug 15 (Reuters) – University of Oklahoma medical student Ian Peake spent four years shadowing doctors...